Mirabegron
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
70710-1159 -
Package NDC
70710-1159-1 -
Package NDC
70710-1159-3 -
Package NDC
70710-1159-9 -
Application number
ANDA209488 -
SPL ID
df34c0c9-8528-4fd6-a408-e1d44da0f156 -
SPL set ID
2e40eb74-3b2a-47f7-bf31-fe27484f9bd2 -
UNII
MVR3JL3B2V -
RxCUI
1300791 -
RxCUI
1300801
What the source publishes
- Labeler
- Zydus Pharmaceuticals (USA) Inc.
- Active ingredients
- Mirabegron
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Mirabegron",
"splId": "df34c0c9-8528-4fd6-a408-e1d44da0f156",
"labels": [
{
"setId": "2e40eb74-3b2a-47f7-bf31-fe27484f9bd2",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2e40eb74-3b2a-47f7-bf31-fe27484f9bd2",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=2e40eb74-3b2a-47f7-bf31-fe27484f9bd2"
}
],
"routes": [
"ORAL"
],
"labeler": "Zydus Pharmaceuticals (USA) Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1159-1)",
"package_ndc": "70710-1159-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20240123"
},
{
"sample": false,
"description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1159-3)",
"package_ndc": "70710-1159-3",
"identifierStatus": "well-formed",
"marketing_start_date": "20240123"
},
{
"sample": false,
"description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (70710-1159-9)",
"package_ndc": "70710-1159-9",
"identifierStatus": "well-formed",
"marketing_start_date": "20240123"
}
],
"productId": "70710-1159_df34c0c9-8528-4fd6-a408-e1d44da0f156",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "70710-1159",
"deaSchedule": null,
"genericName": "Mirabegron",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "MIRABEGRON",
"strength": "25 mg/1"
}
],
"applicationNumber": "ANDA209488",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20240123",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000185008",
"N0000185007",
"N0000182137",
"N0000190114",
"N0000185503"
],
"unii": [
"MVR3JL3B2V"
],
"rxcui": [
"1300791",
"1300801"
],
"spl_set_id": [
"2e40eb74-3b2a-47f7-bf31-fe27484f9bd2"
],
"pharm_class_epc": [
"beta3-Adrenergic Agonist [EPC]"
],
"pharm_class_moa": [
"Adrenergic beta3-Agonists [MoA]",
"Cytochrome P450 2D6 Inhibitors [MoA]",
"Cytochrome P450 3A Inhibitors [MoA]",
"P-Glycoprotein Inhibitors [MoA]"
],
"manufacturer_name": [
"Zydus Pharmaceuticals (USA) Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:70710-1159_df34c0c9-8528-4fd6-a408-e1d44da0f156"